West Pharmaceutical Services PE Ratio 2012-2026 | WST
Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of June 11, 2026 is 35.19.
| West Pharmaceutical Services PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-11 | 330.34 | 44.16 | |
| 2026-03-31 | 250.45 | $7.48 | 33.48 |
| 2025-12-31 | 274.68 | $6.79 | 40.45 |
| 2025-09-30 | 261.68 | $6.75 | 38.77 |
| 2025-06-30 | 218.08 | $6.68 | 32.65 |
| 2025-03-31 | 222.92 | $6.37 | 35.00 |
| 2024-12-31 | 325.95 | $6.69 | 48.72 |
| 2024-09-30 | 298.50 | $6.74 | 44.29 |
| 2024-06-30 | 327.35 | $7.03 | 46.56 |
| 2024-03-31 | 393.04 | $7.58 | 51.85 |
| 2023-12-31 | 349.56 | $7.88 | 44.36 |
| 2023-09-30 | 372.26 | $7.42 | 50.17 |
| 2023-06-30 | 379.27 | $6.87 | 55.21 |
| 2023-03-31 | 343.39 | $7.29 | 47.10 |
| 2022-12-31 | 233.09 | $7.73 | 30.15 |
| 2022-09-30 | 243.52 | $8.26 | 29.48 |
| 2022-06-30 | 299.03 | $8.98 | 33.30 |
| 2022-03-31 | 405.98 | $8.97 | 45.26 |
| 2021-12-31 | 463.39 | $8.67 | 53.45 |
| 2021-09-30 | 419.27 | $8.05 | 52.08 |
| 2021-06-30 | 354.48 | $6.83 | 51.90 |
| 2021-03-31 | 278.01 | $5.57 | 49.91 |
| 2020-12-31 | 279.36 | $4.57 | 61.13 |
| 2020-09-30 | 270.91 | $4.14 | 65.44 |
| 2020-06-30 | 223.74 | $3.80 | 58.88 |
| 2020-03-31 | 149.81 | $3.47 | 43.17 |
| 2019-12-31 | 147.77 | $3.21 | 46.03 |
| 2019-09-30 | 139.25 | $3.04 | 45.80 |
| 2019-06-30 | 122.73 | $3.02 | 40.64 |
| 2019-03-31 | 107.93 | $2.89 | 37.35 |
| 2018-12-31 | 95.87 | $2.74 | 34.99 |
| 2018-09-30 | 120.59 | $2.06 | 58.54 |
| 2018-06-30 | 96.84 | $2.00 | 48.42 |
| 2018-03-31 | 85.98 | $1.76 | 48.85 |
| 2017-12-31 | 95.95 | $1.99 | 48.21 |
| 2017-09-30 | 93.47 | $2.50 | 37.39 |
| 2017-06-30 | 91.65 | $2.33 | 39.33 |
| 2017-03-31 | 79.00 | $2.42 | 32.65 |
| 2016-12-31 | 81.99 | $1.91 | 42.93 |
| 2016-09-30 | 71.88 | $1.85 | 38.85 |
| 2016-06-30 | 73.10 | $1.37 | 53.36 |
| 2016-03-31 | 66.67 | $1.15 | 57.97 |
| 2015-12-31 | 57.79 | $1.30 | 44.46 |
| 2015-09-30 | 51.83 | $1.27 | 40.81 |
| 2015-06-30 | 55.52 | $1.68 | 33.05 |
| 2015-03-31 | 57.44 | $1.82 | 31.56 |
| 2014-12-31 | 50.68 | $1.75 | 28.96 |
| 2014-09-30 | 42.51 | $1.65 | 25.76 |
| 2014-06-30 | 39.96 | $1.59 | 25.13 |
| 2014-03-31 | 41.63 | $1.50 | 27.75 |
| 2013-12-31 | 46.28 | $1.57 | 29.47 |
| 2013-09-30 | 38.73 | $1.56 | 24.83 |
| 2013-06-30 | 32.98 | $1.40 | 23.56 |
| 2013-03-31 | 30.39 | $1.20 | 25.43 |
| 2012-12-31 | 25.53 | $1.15 | 22.20 |
| 2012-09-30 | 24.66 | $1.11 | 22.22 |
| 2012-06-30 | 23.38 | $1.15 | 20.42 |
| 2012-03-31 | 19.61 | $1.21 | 16.27 |
| 2011-12-31 | 17.41 | $1.08 | 16.12 |
| 2011-09-30 | 16.94 | $0.91 | 18.72 |
| 2011-06-30 | 19.91 | $0.92 | 21.76 |
| 2011-03-31 | 20.29 | $0.94 | 21.59 |
| 2010-12-31 | 18.60 | $0.95 | 19.68 |
| 2010-09-30 | 15.41 | $1.15 | 13.46 |
| 2010-06-30 | 16.32 | $1.14 | 14.32 |
| 2010-03-31 | 18.69 | $1.12 | 16.76 |
| 2009-12-31 | 17.39 | $1.06 | 16.41 |
| 2009-09-30 | 17.95 | $1.03 | 17.51 |
| 2009-06-30 | 15.34 | $0.98 | 15.73 |
| 2009-03-31 | 14.38 | $1.10 | 13.07 |
| 2008-12-31 | 16.47 | $1.25 | 13.18 |
| 2008-09-30 | 21.21 | $1.09 | 19.55 |
| 2008-06-30 | 18.75 | $1.07 | 17.60 |
| 2008-03-31 | 19.10 | $1.02 | 18.73 |
| 2007-12-31 | 17.47 | $1.03 | 17.04 |
| 2007-09-30 | 17.87 | $1.15 | 15.54 |
| 2007-06-30 | 20.17 | $1.17 | 17.32 |
| 2007-03-31 | 19.81 | $1.11 | 17.85 |
| 2006-12-31 | 21.80 | $1.00 | 21.80 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $18.493B | $3.074B |
| West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Cooper (COO) | United States | $13.894B | 16.52 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |